'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)

PHASE2RecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

December 22, 2020

Primary Completion Date

February 29, 2028

Study Completion Date

February 29, 2032

Conditions
NSCLC/Oligometastatic Cancer (Single Lung Lesion)
Interventions
RADIATION

Image-Guided Stereotactic Ablative Radiotherapy (IG-SABR)

Image-Guided Stereotactic Ablative Radiotherapy (IG-SABR) delivered in 8 fractions of 7.5 Gy. OAR constraints must be respected but a minimum dose coverage to 95% of the PTV will be allowed down to 75% and a minimum dose to 99% of the GTV allowed at 75%. Respiratory monitoring/active respiratory management will be used. Plans will be created and delivered using photon beams with energies between 6-10 MV.

Trial Locations (2)

Unknown

RECRUITING

Beacon Hospital, Dublin

RECRUITING

St Luke's Radiation Oncology Network (SLRON) at St Luke's Hospital and St James's Hospital, Dublin

All Listed Sponsors
collaborator

Technological University Dublin

UNKNOWN

collaborator

University College Dublin

OTHER

lead

Cancer Trials Ireland

NETWORK